Advertisement

Month: May 2020

April 2020 Briefing – Allergy

Here are what the editors at HealthDay consider to be the most important developments in Allergy for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Cardiology

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. […]

Read More

April 2020 Briefing – Family Practice

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened […]

Read More

April 2020 Briefing – Gastroenterology

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. […]

Read More

April 2020 Briefing – Infectious Disease

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened […]

Read More

April 2020 Briefing – Neurology

Here are what the editors at HealthDay consider to be the most important developments in Neurology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Nursing

Here are what the editors at HealthDay consider to be the most important developments in Nursing for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – OBGYN & Women’s Health

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in […]

Read More

April 2020 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. […]

Read More

April 2020 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Orthopedics

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Pediatrics

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Psychiatry

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

April 2020 Briefing – Pulmonology

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for April 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Symptomatic Health Care Staff in U.K. Screened for […]

Read More

For latest news and updates
Email-id is invalid